Woodline Partners LP Novo Cure LTD Transaction History

Woodline Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $4.36 Million - $6.18 Million	391,459 New	391,459 $5.84 Million
Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $4.18 Million - $6.65 Million	73,925 New	73,925 $5.14 Million
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $622,131 - $874,190	-10,343 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $776,552 - $1.26 Million	10,343 New	10,343 $777,000

262

76.9M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.75B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.